English / TurkishFrench / Espanol / Italian / German / Dutch

Table of Contents:

  • The Name or Trade Name of The Medical Device
  • The Name and The Address of The Manufacturer
  • Product Content List
  • Intended Use of The Product
  • The Performance of The Device Intended by The Manufacturer
  • Clinical Safety Information
  • Residual Risk Information and Side Effect Information
  • User Profile
  • Procedure
  • Storage, Shelf Life and Handling Information
  • Precautions, Warnings, Measures to Be Taken and Limitations
  • Patient Profile and Possible Contraindicative Situations
  • Symbols and Explanations

The Name or Trade Name of the Medical Device

PRP KIT
The product is a PRP KIT, sterile, single use medical device.

The Name and the Address of the Manufacturer

T-Biyoteknoloji Laboratuvar Estetik Medikal Kozmetik San. Tic. Ltd. Şti.
Tahtalı Mh. Değirmen Yolu (460) Sk. No:10 16280 Nilüfer / Bursa / Turkey
Phone: +90 224 246 8522
E-mail: info@tlab.com.tr

Product Content List

  • 2 units of PRP Tube(s)
  • 1 unit of Re-suspension Tube
  • 1 unit of Long Needle
  • 1 unit of Holder
  • 1 unit of 1ml Injector
  • 1 unit of 5ml Injector
  • 1 unit of 30G needle
  • 1 unit of 21G needle
  • 1 unit of Blood Collection Needle

Intended Use of the Product

The device is designed to be used for the safe and rapid preparation of autologous platelet-rich-plasma (PRP) from a small sample of blood at the patient’s point of care. The PRP is prepared prior to application to a local area of soft tissue or hard tissue (including bone) site as deemed necessary by the clinical use requirements. And its intended use is for the application of PRP in order to achieve the stimulation of soft tissue and hard tissue (including bone) and acceleration of soft tissue and hard tissue (including bone) healing.

The Performance of the Device Intended by the Manufacturer

PRP (Platelet Rich Plasma) is used for many years in the frame of regenerative medicine, which allows the cellular healing on bone and soft tissue recovery. Bone and soft tissue healing is occurred by the platelet concentration and re-injection locally to the related part of the body.

Concentration of platelets with buffy coat layer is very important for PRP treatments. Currently accepted technique for avoiding coagulation of the whole blood, referred to Sodium Citrate. The procedure uses anticoagulated blood, collected by routine phlebotomy. Buffered Citrate Solution blocks the coagulation by mixing gently the whole blood together with 3,20% concentrated 0,1M of Sodium Citrate. This preparation is then centrifuged to concentrate the PRP layer. Recommended G force for the concentration is 830 G. The blood separation system takes the advantage of centrifugational force effecting on the weight of the cells. The separation occurs during centrifugation when the denser blood components move due to a gravity force.

The PRP Tube shall not be mixed after the centrifugation. 2ml of layer is harvested carefully above the erythrocytes. (Red Blood Cell layer) The collected PRP layer is moved to Re-suspension tube for re-suspension process.

The result is a convenient tube system, collection of the whole blood and concentration of Platelet Rich Plasma. PRP Tubes included in PRP KIT are interior sterilized using irradiation. PRP KIT reduces the risk of air contamination, eliminates the need of any other tubes or pipettes.

Clinical Safety Information

The safety and efficacy of this device has been proven by Risk Analysis Report and Clinical Evaluation Report, attached to the Technical File of PRP Kit.

Residual Risk and Side Effects Information

According to the risk assessment, risk management, risk report procedures of this device, it shows no residual risks. With respect to the requirements of Essential Requirements 6, the risk management report showed that there were no serious side effects and the performance of the product was verified by the clinical evaluation report.

User Profile

This product should be used by physicians or physician-directed allied health care professionals with adequate training in the use of the device.

Procedure

Apply the following instructions to obtain Platelet Rich Plasma by using PRP KIT:

  • Open the box.
  • Open the sterile blister package.
  • Attach Blood Collection Needle to Holder.
  • Apply the Blood Collection Needle to sanitized part of the patient’s arm. (Venous)
  • Attach PRP Tube inside the holder to Blood Collection Needle. (Routine Phlebotomy)
  • PRP Tube is a vacuumed tube. The tube collects enough amount of blood and stops itself. (Apply both tubes, without removing the Blood Collection Needle from the vessel.)
  • Centrifuge both tubes in a centrifuging device at 830 G for 8 minutes. Buckets shall be compatible for PRP Tubes (16 X 100 mm tube size).
  • Attach Long Needle to 5ml Luer-lok Syringe.
  • Collect the PRP by sticking the Long needle into the PRP Tube above the RBC Layer (Do not open the Lid of the tube unless it is not performed under Laminar Flow Conditions)
  • Collect carefully 2ml of PRP Layer.
  • Carry PRP to the Re-suspension Tube.
  • Apply again the same protocol for the other PRP Tube.
  • Carry again PRP to the Re-suspension tube.
  • You have app. 4 ml of PRP inside the Re-suspension tube. (Re-suspension tube is 10 ml capacity sterile tube)
  • Gently shake the Re-suspension tube for 30 seconds to homogenize the settlement of the possible clumped cells in the plasma milieu. (Re-suspension process)
  • Attach the application needle (Green Needle - 21G) to 1ml Luer-Lok syringe.
  • Collect the re-suspended PRP inside from the Re-Suspension Tube.
  • Change application needle (green needle - 21G) to injection needle (yellow needle - 30G)
  • Apply the injection method to the patient.

Storage, Product Life and Handling Information

  • Do not expose to direct sunlight.
  • Do not use if the inner sterile blister package is damaged or opened.
  • Shelf life (Product Lifecycle) is the expiration date on the label.

Precautions, Warnings, Measures to Be Taken and Limitations

  • Use proper safety precautions to guard against needle sticks.
  • Follow manufacturer instructions when using centrifuge.
  • Do not use sterile component of this kit if package is opened or damaged.
  • Do not open the lids of the tubes.
  • Single use device, do not reuse.
  • The user should be thoroughly familiar with the equipment and the surgical procedure prior to using this device.
  • The patient should be made aware of general risks associated with treatment and possible adverse effects.
  • Do not dispose of this product in the unsorted municipal waste stream.
  • Long Needle is not intended to be used on human. It is just intended to be used to collect PRP Layer inside from the PRP Tube(s).

Patient Profile and Possible Contraindicative Situations

Patient Profile

Platelet rich plasma is an autologous application technique and it is used on the same patient. Due to this information, platelet-rich plasma applications are inherently safe from infectious diseases such as HIV, Hepatitis, Creutzfeldt-Jakob disease.

As an autologous technique; however, Platelet-Rich Plasma can be used safe and effectively to all patients, there may have a need for further studies on pregnant and newborns.

Possible Contraindicative Situations

  • Platelet Dysfunction Syndrome
  • Critical Thrombocytopaenia
  • Hypofibrinogenaemia
  • Hemodynamic instability
  • Auto-immune diseases
  • Malignancy
  • Sepsis
  • Acute Chronic infections
  • Chronic Liver Pathology
  • Anti-coagulation Therapy (ASA therapy etc.)
  • Pregnancy (for cosmetic indications)
  • Newborns

Symbols and Explanations (Product Label & IFU)

Manufacturer
blank
Date of Manufacture
blank
Use By Date
blank
Batch Code
blank
Catalogue Number
blank
Sterilized Using Ethylene Oxide
blank
Sterilized Using Irradiation
blank
Do Not Re-sterilize
blank
Do Not Use if Package is Damaged
blank
Keep Away from Sunlight
blank
Keep Dry
blank
Temperature Limit
blank
Do Not Reuse
blank
Consult Instructions for Use
Dikkat
Caution
blank
Notified Body

TF01.IFU.R9   |   Release Date: 05/03/2014   |   Revision Date: 08/04/2020